短链脂肪酸对类风湿性关节炎的改善作用及中药的调控
Ameliorative Effect of Short Chain Fatty Acids on Rheumatoid Arthritis and Regulation of Traditional Chinese Medicines
摘要: 类风湿性关节炎是一种有“不死的癌症”之称的慢性全身性免疫疾病,是临床多发且难治的关节运动性疾病之一。短链脂肪酸是肠道菌群的重要代谢产物,具有抑制炎症和调节免疫等生物活性,对类风湿性关节炎具有改善作用。此外,许多中药可通过调控肠道菌群促进短链脂肪酸产生,呈现抗关节炎效应。本文从短链脂肪酸在类风湿性关节炎疾病状态下的变化,对疾病的改善作用和机制,中药调控短链脂肪酸治疗类风湿性关节炎以及短链脂肪酸的应用等方面进行综述,为认识类风湿性关节炎的病机、促进相关药物的研发及阐明中药的作用机制提供参考。
Abstract: Rheumatoid arthritis (RA) is a chronic systemic immune disease known as “cancer that never dies”. It is one of the most common and refractory joint motor diseases in clinic. Short-chain fatty acids are important metabolites of intestinal flora, which have biological activities such as inhibiting inflammation and regulating immunity, and can improve rheumatoid arthritis. In addition, many traditional Chinese medicines can promote the production of short-chain fatty acids by regulating intestinal flora, showing anti-arthritis effect. In this paper, the changes of short-chain fatty acids in the disease state of rheumatoid arthritis, the improvement effect and mechanism of the disease, the regulation of short-chain fatty acids by Chinese medicines in the treatment of rheumatoid arthritis and the application of short-chain fatty acids were reviewed, so as to provide reference for elucidat-ing the pathogenesis of rheumatoid arthritis, promoting the research and development of related drugs and clarifying the mechanism of action of Chinese medicines.
文章引用:廖明慧, 戴岳. 短链脂肪酸对类风湿性关节炎的改善作用及中药的调控[J]. 药物资讯, 2023, 12(3): 255-260. https://doi.org/10.12677/PI.2023.123032

参考文献

[1] Ahmed, E. and Alzahrani, A. (2023) SOXC Transcription Factors as Diagnostic Biomarkers and Therapeutic Targets for Arthritis. International Journal of Molecular Sciences, 24, 4215. [Google Scholar] [CrossRef] [PubMed]
[2] Zhang, M., Hu, W., et al. (2022) Advanced Application of Stimuli-Responsive Drug Delivery System for Inflammatory Arthritis Treatment. Materials Today Bio, 14, Article ID: 100223. [Google Scholar] [CrossRef] [PubMed]
[3] Shlobin, N.A. and Dahdaleh, N.S. (2021) Cervical Spine Manifestations of Rheumatoid Arthritis: A Review. Neurosurgical Re-view, 44, 1957-1965. [Google Scholar] [CrossRef] [PubMed]
[4] Wu, D., Luo, Y., Li, T., et al. (2022) Sys-temic Complications of Rheumatoid Arthritis: Focus on Pathogenesis and Treatment. Frontiers in Immunology, 13, Arti-cle ID: 1051082. [Google Scholar] [CrossRef] [PubMed]
[5] Enginar, A. and Nur, H. (2023) The Frequency and Factors Affecting Anxiety and Depression in Patients with Rheumatoid Arthritis. Reumatologia, 61, 30-37. [Google Scholar] [CrossRef] [PubMed]
[6] Shams, S., Martinez, J., Dawson, J., et al. (2021) The Therapeutic Landscape of Rheumatoid Arthritis: Current State and Future Directions. Frontiers in Immunology, 12, Article ID: 680043. [Google Scholar] [CrossRef] [PubMed]
[7] Abbasi, M., Mousavi, M., Jamalzehi, S., et al. (2019) Strategies toward Rheumatoid Arthritis Therapy; the Old and the New. Journal of Cellular Physiology, 234, 10018-10031. [Google Scholar] [CrossRef] [PubMed]
[8] Ikeda, T., Nishida, A., Yamano, M., et al. (2022) Short-Chain Fatty Acid Receptors and Gut Microbiota as Therapeutic Targets in Metabolic, Immune, and Neurological Diseases. Pharmacology & Therapeutics, 239, Article ID: 108273. [Google Scholar] [CrossRef] [PubMed]
[9] Yang, W., Yu, T., Huang, X., et al. (2020) Intestinal Mi-crobiota-Derived Short-Chain Fatty Acids Regulation of Immune Cell IL-22 Production and Gut Immunity. Nature Communications, 11, Article No. 4457. [Google Scholar] [CrossRef] [PubMed]
[10] Barbara, G., Barbaro, M., Fuschi, D., et al. (2021) Inflammatory and Microbiota-Related Regulation of the Intestinal Epithelial Barrier. Frontiers in Nutrition, 8, Article ID: 718356. [Google Scholar] [CrossRef] [PubMed]
[11] Li, M., Esch, B., Wagenaar, G., et al. (2018) Pro- and An-ti-Inflammatory Effects of Short Chain Fatty Acids on Immune and Endothelial Cells. European Journal of Pharmacol-ogy, 831, 52-59. [Google Scholar] [CrossRef] [PubMed]
[12] Rogier, C., Wouters, F., van Boheemen, L., et al. (2021) Subclinical Synovitis in Arthralgia: How Often Does It Result in Clinical Arthritis? Reflecting on Starting Points for Disease-Modifying Anti-Rheumatic Drug Treatment. Rheumatology (Oxford), 60, 3872-3878. [Google Scholar] [CrossRef] [PubMed]
[13] Martinsson, K., Dürholz, K., Schett, G., et al. (2022) Higher Serum Levels of Short-Chain Fatty Acids Are Associated with Non-Progression to Arthritis in Individuals at Increased Risk of RA. Annals of the Rheumatic Diseases, 81, 445-447. [Google Scholar] [CrossRef] [PubMed]
[14] Marazzato, M., Iannuccelli, C., Guzzo, M., et al. (2022) Gut Microbiota Structure and Metabolites, before and after Treatment in Early Rheumatoid Arthritis Patients: A Pilot Study. Frontiers in Medicine, 9, Article ID: 921675. [Google Scholar] [CrossRef] [PubMed]
[15] Rosser, E., Piper, C., Matei, D., et al. (2020) Microbiota-Derived Metabolites Suppress Arthritis by Amplifying Aryl-Hydrocarbon Receptor Activation in Regulatory B Cells. Cell Me-tabolism, 31, 837-851. [Google Scholar] [CrossRef] [PubMed]
[16] Yao, Y., Cai, X., Zheng, Y., et al. (2022) Short-Chain Fatty Acids Regulate B Cells Differentiation via the FFA2 Receptor to Alleviate Rheumatoid Arthritis. British Journal of Pharma-cology, 179, 4315-4329. [Google Scholar] [CrossRef] [PubMed]
[17] Hui, W., Yu, D., Cao, Z., et al. (2019) Butyrate Inhibitcollagen-Induced Arthritis via Treg/IL-10/Th17 Axis. International Immunopharmacology, 68, 226-233. [Google Scholar] [CrossRef] [PubMed]
[18] Bai, Y., Li, Y., Marion, T., et al. (2021) Resistant Starch Intake Alleviates Collagen-Induced Arthritis in Mice by Modulating Gut Microbiota and Promoting Concomitant Propionate Production. Journal of Autoimmunity, 116, Article ID: 102564. [Google Scholar] [CrossRef] [PubMed]
[19] He, J., Chu, Y., Li, J., et al. (2022) Intestinal Butyrate-Metabolizing Species Contribute to Autoantibody Production and Bone Erosion in Rheumatoid Arthritis. Science Advances, 8, eabm1511. [Google Scholar] [CrossRef] [PubMed]
[20] Ma, S., Wang, J., He, F., et al. (2022) Sodium Propionate Improves Rheumatoid Arthritis by Inhibiting Surviving Mediated Proliferation of Fibroblast like Synoviocytes by Promoting miR-140-5p. Autoimmunity, 55, 378-387. [Google Scholar] [CrossRef] [PubMed]
[21] Lee, S., Koh, J., Chang, Y., et al. (2019) Invariant NKT Cells Functionally Link Microbiota-Induced Butyrate Production and Joint Inflammation. The Journal of Immunology, 203, 3199-3208. [Google Scholar] [CrossRef] [PubMed]
[22] Takahashi, D., Hoshina, N., Kabumoto, Y., et al. (2020) Microbiota-Derived Butyrate Limits the Autoimmune Response by Promoting the Differentiation of Follicular Regulatory T Cells. EBioMedicine, 58, Article ID: 102913. [Google Scholar] [CrossRef] [PubMed]
[23] Gondalia, S., Wymond, B., Benassi-Evans, B., et al. (2022) Substitution of Refined Conventional Wheat Flour with Wheat High in Resistant Starch Modulates the Intestinal Micro-biota and Fecal Metabolites in Healthy Adults: A Randomized, Controlled Trial. Journal of Nutrition, 152, 1426-1437. [Google Scholar] [CrossRef] [PubMed]
[24] Bungau, S., Behl, T., Singh, A., et al. (2021) Targeting Probiotics in Rheumatoid Arthritis. Nutrients, 13, 3376. [Google Scholar] [CrossRef] [PubMed]
[25] Fan, Z., Ross, R., Stanton, C., et al. (2021) Lactobacillus casei CCFM1074 Alleviates Collagen-Induced Arthritis in Rats via Balancing Treg/Th17 and Modulating the Metabolites and Gut Microbiota. Frontiers in Immunology, 12, Article ID: 680073. [Google Scholar] [CrossRef] [PubMed]
[26] Wang, J., Kuo, C., Kuo, F., et al. (2019) Fecal Microbiota Trans-plantation: Review and Update. Journal of the Formosan Medical Association, 118, S23-S31. [Google Scholar] [CrossRef] [PubMed]
[27] Marietta, E., Mangalam, A., Taneja, V., et al. (2020) Intestinal Dysbiosis in, and Enteral Bacterial Therapies for, Systemic Autoimmune Diseases. Frontiers in Immunology, 11, Article ID: 573079. [Google Scholar] [CrossRef] [PubMed]
[28] Zeng, J., Peng, L., Zheng, W., et al. (2020) Fecal Microbiota Transplantation for Rheumatoid Arthritis: A Case Report. Clinical Case Reports, 9, 906-909. [Google Scholar] [CrossRef] [PubMed]
[29] Huang, C., Yi, P., Zhu, M., et al. (2022) Safety and Efficacy of Fecal Mi-crobiota Transplantation for Treatment of Systemic Lupus Erythematosus: An Explorer Trial. Journal of Autoimmunity, 130, Article ID: 102844. [Google Scholar] [CrossRef] [PubMed]
[30] Cheng, X., Pi, Z., Zheng, Z., et al. (2022) Combined 16S rRNA Gene Sequencing and Metabolomics to Investigate the Protective Effects of Wu-Tou Decoction on Rheumatoid Arthritis in Rats. Journal of Chromatography B, 1199, Article ID: 123249. [Google Scholar] [CrossRef] [PubMed]
[31] Liu, Y., Liu, L., Luo, J., et al. (2023) Metabolites from Specif-ic Intestinal Bacteria in Vivo Fermenting Lycium barbarum Polysaccharide Improve Collagenous Arthritis in Rats. Inter-national Journal of Biological Macromolecules, 226, 1455-1467. [Google Scholar] [CrossRef] [PubMed]
[32] Shan, J., Peng, L., Qian, W., et al. (2018) Integrated Serum and Fecal Metabolomics Study of Collagen-Induced Arthritis Rats and the Therapeutic Effects of the Zushima Tablet. Fron-tiers in Pharmacology, 9, Article No. 891. [Google Scholar] [CrossRef] [PubMed]
[33] Yue, M., Tao, Y., Fang, Y., et al. (2019) The Gut Microbiota Mod-ulator Berberine Ameliorates Collagen-Induced Arthritis in Rats by Facilitating the Generation of Butyrate and Adjusting the Intestinal Hypoxia and Nitrate Supply. The FASEB Journal, 33, 12311-12323. [Google Scholar] [CrossRef
[34] Pang, J., Ma, S., Xu, X., et al. (2021) Effects of Rhizome of At-ractylodeskoreana (Nakai) Kitam on Intestinal Flora and Metabolites in Rats with Rheumatoid Arthritis. Journal of Eth-nopharmacology, 281, Article ID: 114026. [Google Scholar] [CrossRef] [PubMed]
[35] Qiao, S., Lian, X., Yue, M., et al. (2020) Regulation of Gut Micro-biota Substantially Contributes to the Induction of Intestinal Treg Cells and Consequent Anti-Arthritis Effect of Madecassoside. International Immunopharmacology, 89, Article ID: 107047. [Google Scholar] [CrossRef] [PubMed]
[36] Blaak, E., Canfora, E., Theis, S., et al. (2020) Short Chain Fatty Acids in Human Gut and Metabolic Health. Beneficial Microbes, 11, 411-455. [Google Scholar] [CrossRef